{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:50:23Z","timestamp":1775148623979,"version":"3.50.1"},"reference-count":122,"publisher":"American Spinal Injury Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"abstract":"\n Objectives<\/jats:title>\n To investigate the effects of salsalate on fasting and postprandial (PP) glycemic, lipidemic, and inflammatory responses in persons with tetraplegia.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This study was a randomized, double-blind, cross-over design. It was conducted at a university laboratory. Ten males aged 25 to 50 years with SCI at C5-8 levels for \u22651 year underwent 1 month of placebo and salsalate (4 g\/day) treatment. Blood samples were drawn before and 4 hours after breakfast and lunch fast-food meal consumption.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Descriptive statistics indicate that fasting and PP glucose values were reduced with salsalate (pre-post mean difference, 4 \u00b1 5 mg\/dL and 8 \u00b1 8 mg\/dL, respectively) but largely unchanged with placebo (0 \u00b1 6 mg\/dL and -0 \u00b1 7 mg\/dL, respectively). Insulin responses were generally reciprocal to glucose, however less pronounced. Fasting free fatty acids were significantly reduced with salsalate (191 \u00b1 216 mg\/dL,\n p<\/jats:italic>\n = .021) but not placebo (-46 \u00b1 116 mg\/dL,\n p<\/jats:italic>\n = .878). Results for triglycerides were similar (25 \u00b1 34 mg\/dL,\n p<\/jats:italic>\n =.045, and 7 \u00b1 29 mg\/dL,\n p<\/jats:italic>\n = .464). Fasting low-density lipoprotein (LDL) levels were higher after salsalate (-10 \u00b1 12 mg\/dL,\n p<\/jats:italic>\n = .025) but not placebo (2 \u00b1 9 mg\/dL,\n p<\/jats:italic>\n = .403) treatment. Inflammatory markers were largely unchanged.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In this pilot trial, descriptive values indicate that salsalate decreased fasting and PP glucose response to fast-food meal challenge at regular intervals in persons with tetraplegia. Positive effects were also seen for some lipid but not for inflammatory response markers. Given the relatively \u201chealthy\u201d metabolic profiles of the participants, it is possible that salsalate's effects may be greater and more consistent in people with less favorable metabolic milieus.<\/jats:p>\n <\/jats:sec>","DOI":"10.46292\/sci22-00033","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T13:27:28Z","timestamp":1685194048000},"page":"1-13","source":"Crossref","is-referenced-by-count":2,"title":["Salsalate Improves Postprandial Glycemic and Some Lipid Responses in Persons With Tetraplegia: A Randomized Clinical Pilot Trial With Crossover Design"],"prefix":"10.46292","volume":"29","author":[{"given":"Jochen","family":"Kressler","sequence":"first","affiliation":[{"name":"The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, Florida"},{"name":"School of Exercise and Nutritional Sciences, San Diego State University, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Mendez","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Betancourt","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Nash","sequence":"additional","affiliation":[{"name":"The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, Florida"},{"name":"Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida"},{"name":"Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida"},{"name":"Department of Rehabilitation Medicine, Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25425","reference":[{"issue":"7","key":"i1945-5763-29-3-1-b1","series-title":"Spinal Cord","first-page":"466","article-title":"Coronary heart disease in individuals with spinal cord injury: Assessment of risk factors","volume":"46","author":"Bauman\n WA","year":"2008","unstructured":"Bauman\n WA\n , SpungenAM. Coronary heart disease in individuals with spinal cord injury: Assessment of risk factors. Spinal Cord. 2008;46(7):466-476."},{"issue":"6","key":"i1945-5763-29-3-1-b2","series-title":"Arch Phys Med Rehabil","first-page":"751","article-title":"A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia","volume":"88","author":"Nash\n MS","year":"2007","unstructured":"Nash\n MS\n , MendezAJ. A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia. Arch Phys Med Rehabil. 2007;88(6):751-757."},{"issue":"2","key":"i1945-5763-29-3-1-b3","series-title":"Assist Technol","first-page":"88","article-title":"Metabolic and endocrine changes in persons aging with spinal cord injury","volume":"11","author":"Bauman\n WA","year":"1999","unstructured":"Bauman\n WA\n , SpungenAM, AdkinsRH, KempBJ. Metabolic and endocrine changes in persons aging with spinal cord injury. Assist Technol. 1999;11(2):88-96."},{"issue":"9","key":"i1945-5763-29-3-1-b4","series-title":"Spinal Cord","first-page":"601","article-title":"Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury","volume":"37","author":"Bauman\n WA","year":"1999","unstructured":"Bauman\n WA\n , KahnNN, GrimmDR, SpungenAM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37(9):601-616."},{"issue":"4","key":"i1945-5763-29-3-1-b5","series-title":"J Spinal Cord Med","first-page":"468","article-title":"Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia","volume":"38","author":"Ellenbroek\n D","year":"2015","unstructured":"Ellenbroek\n D\n , KresslerJ, CowanRE, BurnsPA, MendezAJ, NashMS. Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia. J Spinal Cord Med. 2015;38(4):468-475."},{"key":"i1945-5763-29-3-1-b6","series-title":"Int J Vasc Med","first-page":"947417","article-title":"Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases","volume":"2012","author":"Klop\n B","year":"2012","unstructured":"Klop\n B\n , ProctorSD, MamoJC, BothamKM, Castro CabezasM. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med. 2012;2012:947417."},{"key":"i1945-5763-29-3-1-b7","series-title":"Can J Cardiol","first-page":"18B","article-title":"Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins","volume":"14","author":"Cohn\n JS","year":"1998","unstructured":"Cohn\n JS\n \n . Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol. 1998;14(Suppl B):18B-27B."},{"issue":"2","key":"i1945-5763-29-3-1-b8","series-title":"Atherosclerosis","first-page":"307","article-title":"Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men","volume":"141","author":"Karpe\n F","year":"1998","unstructured":"Karpe\n F\n , de FaireU, MercuriM, BondMG, HelleniusML, HamstenA. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis. 1998;141(2):307-314."},{"issue":"1","key":"i1945-5763-29-3-1-b9","series-title":"Int J Cardiol","first-page":"3","article-title":"Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus","volume":"126","author":"Pastromas\n S","year":"2008","unstructured":"Pastromas\n S\n , TerziAB, TousoulisD, KoulourisS. Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol. 2008;126(1):3-12."},{"issue":"1","key":"i1945-5763-29-3-1-b10","series-title":"Cardiovasc Diabetol","first-page":"61","article-title":"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins","volume":"10","author":"Ansar\n S","year":"2011","unstructured":"Ansar\n S\n , KoskaJ, ReavenPD. Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins. Cardiovasc Diabetol. 2011;10(1):61."},{"issue":"4","key":"i1945-5763-29-3-1-b11","series-title":"J Spinal Cord Med","first-page":"320","article-title":"Evidence for an exaggerated postprandial lipemia in chronic paraplegia","volume":"28","author":"Nash\n MS","year":"2005","unstructured":"Nash\n MS\n , DeGrootJ, Martinez-ArizalaA, MendezAJ. Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med. 2005;28(4):320-5."},{"issue":"5","key":"i1945-5763-29-3-1-b12","series-title":"J Am Coll Nutr","first-page":"476","article-title":"The influence of visceral fat on the postprandial lipemic response in men with paraplegia","volume":"29","author":"Emmons\n RR","year":"2010","unstructured":"Emmons\n RR\n , GarberCE, CirnigliaroCM, et al.\n The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr. 2010;29(5):476-81."},{"key":"i1945-5763-29-3-1-b13","series-title":"MSSE","first-page":"404","article-title":"Exaggerated postprandial triglyceride response identified in individuals with spinal cord injury with cardiac risk factors","volume":"41","author":"Emmons\n RR","year":"2009","unstructured":"Emmons\n RR\n , CirnigliaroCM, MoyerJM, et al.\n Exaggerated postprandial triglyceride response identified in individuals with spinal cord injury with cardiac risk factors. MSSE. 2009;41(5 Suppl 1):404-405."},{"key":"i1945-5763-29-3-1-b14","series-title":"Int J Obes Relat Metab Disord","first-page":"S29","article-title":"Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging","volume":"27","author":"Tracy\n RP","year":"2003","unstructured":"Tracy\n RP\n \n . Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S29-34."},{"issue":"3","key":"i1945-5763-29-3-1-b15","series-title":"Rev Endocr Metab Disord","first-page":"255","article-title":"Inflammation in atherosclerosis and diabetes mellitus","volume":"5","author":"Plutzky\n J","year":"2004","unstructured":"Plutzky\n J\n \n . Inflammation in atherosclerosis and diabetes mellitus. Rev Endocr Metab Disord. 2004;5(3):255-259."},{"issue":"10","key":"i1945-5763-29-3-1-b16","series-title":"Circulation","first-page":"1211","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment","volume":"106","author":"Ceriello\n A","year":"2002","unstructured":"Ceriello\n A\n , TabogaC, TonuttiL, et al.\n Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment. Circulation. 2002;106(10):1211-1218."},{"issue":"4","key":"i1945-5763-29-3-1-b17","series-title":"J Clin Invest","first-page":"635","article-title":"Acute hyperglycemia induces an oxidative stress in healthy subjects","volume":"108","author":"Marfella\n R","year":"2001","unstructured":"Marfella\n R\n , QuagliaroL, NappoF, CerielloA, GiuglianoD. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001;108(4):635-636."},{"issue":"2","key":"i1945-5763-29-3-1-b18","series-title":"Atherosclerosis","first-page":"517","article-title":"Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress","volume":"155","author":"Bae\n JH","year":"2001","unstructured":"Bae\n JH\n , BassengeE, KimKB, KimYN, KimKS, LeeHJ, et al.\n Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001;155(2):517-523."},{"issue":"3","key":"i1945-5763-29-3-1-b19","series-title":"Diabetes","first-page":"701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello\n A","year":"2004","unstructured":"Ceriello\n A\n , QuagliaroL, PiconiL, et al.\n Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes. 2004;53(3):701-710."},{"issue":"2","key":"i1945-5763-29-3-1-b20","series-title":"Am Heart J","first-page":"218","article-title":"Endothelial dysfunction: Clinical strategies for treating oxidant stress","volume":"146","author":"Fenster\n BE","year":"2003","unstructured":"Fenster\n BE\n , TsaoPS, RocksonSG. Endothelial dysfunction: Clinical strategies for treating oxidant stress. Am Heart J. 2003;146(2):218-226."},{"issue":"23","key":"i1945-5763-29-3-1-b21","series-title":"Circulation","first-page":"3599","article-title":"Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles","volume":"110","author":"Ferreira\n AC","year":"2004","unstructured":"Ferreira\n AC\n , PeterAA, MendezAJ, et al.\n Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation. 2004;110(23):3599-3603."},{"issue":"9","key":"i1945-5763-29-3-1-b22","series-title":"Circulation","first-page":"1135","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby\n P","year":"2002","unstructured":"Libby\n P\n , RidkerPM, MaseriA. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143."},{"issue":"1","key":"i1945-5763-29-3-1-b23","series-title":"Hypertension","first-page":"6","article-title":"C-reactive protein: Risk marker or mediator in atherothrombosis?","volume":"44","author":"Jialal\n I","year":"2004","unstructured":"Jialal\n I\n , DevarajS, VenugopalSK. C-reactive protein: Risk marker or mediator in atherothrombosis?Hypertension. 2004;44(1):6-11."},{"issue":"2","key":"i1945-5763-29-3-1-b24","series-title":"Semin Dial","first-page":"129","article-title":"Inflammatory biomarkers and cardiovascular risk: Association or cause and effect?","volume":"19","author":"Rao\n M","year":"2006","unstructured":"Rao\n M\n , JaberBL, BalakrishnanVS. Inflammatory biomarkers and cardiovascular risk: Association or cause and effect?Semin Dial. 2006;19(2):129-135."},{"issue":"21","key":"i1945-5763-29-3-1-b25","series-title":"N Engl J Med","first-page":"2195","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker\n PM","year":"2008","unstructured":"Ridker\n PM\n , DanielsonE, FonsecaFA, et al.\n Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-207."},{"issue":"4","key":"i1945-5763-29-3-1-b26","series-title":"Am J Pathol","first-page":"1139","article-title":"C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance","volume":"167","author":"Sun\n H","year":"2005","unstructured":"Sun\n H\n , KoikeT, IchikawaT, HatakeyamaK, ShiomiM, ZhangB, et al.\n C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance. Am J Pathol. 2005;167(4):1139-1148."},{"issue":"1","key":"i1945-5763-29-3-1-b27","series-title":"Diabetes Metab","first-page":"65","article-title":"Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects","volume":"29","author":"Guerrero-Romero\n F","year":"2003","unstructured":"Guerrero-Romero\n F\n , Rodriguez-MoranM. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects. Diabetes Metab. 2003;29(1):65-71."},{"issue":"2","key":"i1945-5763-29-3-1-b28","series-title":"Atherosclerosis","first-page":"387","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen\n E","year":"2003","unstructured":"Leinonen\n E\n , Hurt-CamejoE, WiklundO, HultenLM, HiukkaA, TaskinenMR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 2003;166(2):387-394."},{"issue":"23","key":"i1945-5763-29-3-1-b29","series-title":"Circulation","first-page":"2908","article-title":"Differentiation between obesity and insulin resistance in the association with C-reactive protein","volume":"106","author":"McLaughlin\n T","year":"2002","unstructured":"McLaughlin\n T\n , AbbasiF, LamendolaC, et al.\n Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106(23):2908-2912."},{"issue":"10","key":"i1945-5763-29-3-1-b30","series-title":"J Am Coll Cardiol","first-page":"2003","article-title":"The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome","volume":"44","author":"Aronson\n D","year":"2004","unstructured":"Aronson\n D\n , SellaR, Sheikh-AhmadM, et al.\n The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004;44(10):2003-2007."},{"issue":"1","key":"i1945-5763-29-3-1-b31","series-title":"Circulation","first-page":"42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS)","volume":"102","author":"Festa\n A","year":"2000","unstructured":"Festa\n A\n , D\u2019AgostinoR, Jr, HowardG, MykkanenL, TracyRP, HaffnerSM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102(1):42-47."},{"issue":"2","key":"i1945-5763-29-3-1-b32","series-title":"J Hum Hypertens","first-page":"149","article-title":"Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension","volume":"19","author":"Bautista\n LE","year":"2005","unstructured":"Bautista\n LE\n , VeraLM, ArenasIA, GamarraG. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19(2):149-154."},{"issue":"11","key":"i1945-5763-29-3-1-b33","series-title":"Metabolism","first-page":"1436","article-title":"Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels","volume":"53","author":"Fredrikson\n GN","year":"2004","unstructured":"Fredrikson\n GN\n , HedbladB, NilssonJA, AlmR, BerglundG, NilssonJ. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism. 2004;53(11):1436-1442."},{"issue":"3","key":"i1945-5763-29-3-1-b34","series-title":"Thromb Res","first-page":"245","article-title":"The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases","volume":"82","author":"Grau\n AJ","year":"1996","unstructured":"Grau\n AJ\n , BuggleF, BecherH, WerleE, HackeW. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996;82(3):245-255."},{"issue":"1","key":"i1945-5763-29-3-1-b35","series-title":"Diabetes Res Clin Pract","first-page":"37","article-title":"Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus","volume":"58","author":"Mojiminiyi\n OA","year":"2002","unstructured":"Mojiminiyi\n OA\n , AbdellaN, MoussaMA, AkanjiAO, Al MohammediH, ZakiM. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2002;58(1):37-44."},{"issue":"6","key":"i1945-5763-29-3-1-b36","series-title":"Hypertension","first-page":"859","article-title":"Inflammation, abdominal obesity, and smoking as predictors of hypertension","volume":"44","author":"Niskanen\n L","year":"2004","unstructured":"Niskanen\n L\n , LaaksonenDE, NyyssonenK, et al.\n Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004;44(6):859-865."},{"issue":"4","key":"i1945-5763-29-3-1-b37","series-title":"Int J Obes Relat Metab Disord","first-page":"443","article-title":"The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state","volume":"27","author":"Tamakoshi\n K","year":"2003","unstructured":"Tamakoshi\n K\n , YatsuyaH, KondoT, et al.\n The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord. 2003;27(4):443-449."},{"issue":"2","key":"i1945-5763-29-3-1-b38","series-title":"Arch Phys Med Rehabil","first-page":"312","article-title":"Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury","volume":"86","author":"Frost\n F","year":"2005","unstructured":"Frost\n F\n , RoachMJ, KushnerI, SchreiberP. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil. 2005;86(2):312-317."},{"issue":"3","key":"i1945-5763-29-3-1-b39","series-title":"Curr Opin Clin Nutr Metab Care","first-page":"271","article-title":"Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection","volume":"5","author":"Lang\n CH","year":"2002","unstructured":"Lang\n CH\n , FrostRA. Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care. 2002;5(3):271-279."},{"issue":"2","key":"i1945-5763-29-3-1-b40","series-title":"Diabetes Care","first-page":"289","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman\n A","year":"2008","unstructured":"Fleischman\n A\n , ShoelsonSE, BernierR, GoldfineAB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 2008;31(2):289-294."},{"issue":"6","key":"i1945-5763-29-3-1-b41","series-title":"Ann Intern Med","first-page":"346","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial","volume":"152","author":"Goldfine\n AB","year":"2010","unstructured":"Goldfine\n AB\n , FonsecaV, JablonskiKA, et al.\n The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial. Ann Intern Med. 2010;152(6):346-357."},{"issue":"1","key":"i1945-5763-29-3-1-b42","series-title":"Clin Transl Sci","first-page":"36","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine\n AB","year":"2008","unstructured":"Goldfine\n AB\n , SilverR, AldhahiW, et al.\n Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci. 2008;1(1):36-43."},{"issue":"3","key":"i1945-5763-29-3-1-b43","series-title":"Diabetologia","first-page":"385","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: Results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska\n J","year":"2009","unstructured":"Koska\n J\n , OrtegaE, BuntJC, et al.\n The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: Results of a randomised double-blind placebo-controlled study. Diabetologia. 2009;52(3):385-393."},{"issue":"5","key":"i1945-5763-29-3-1-b44","series-title":"J Spinal Cord Med","first-page":"538","article-title":"International standards for neurological classification of spinal cord injury: Training effect on accurate classification","volume":"31","author":"Chafetz\n RS","year":"2008","unstructured":"Chafetz\n RS\n , VogelLC, BetzRR, GaughanJP, MulcaheyMJ. International standards for neurological classification of spinal cord injury: Training effect on accurate classification. J Spinal Cord Med. 2008;31(5):538-542."},{"issue":"1","key":"i1945-5763-29-3-1-b45","series-title":"J Spinal Cord Med","first-page":"2","article-title":"Circuit resistance training improves the atherogenic lipid profiles of persons with chronic paraplegia","volume":"24","author":"Nash\n MS","year":"2001","unstructured":"Nash\n MS\n , JacobsPL, MendezAJ, GoldbergRB. Circuit resistance training improves the atherogenic lipid profiles of persons with chronic paraplegia. J Spinal Cord Med. 2001;24(1):2-9."},{"key":"i1945-5763-29-3-1-b46","series-title":"Methods Enzymol","first-page":"78","article-title":"Precipitation methods for quantification of lipoproteins","volume":"129","author":"Bachorik\n PS","year":"1986","unstructured":"Bachorik\n PS\n , AlbersJJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986;129:78-100."},{"issue":"6","key":"i1945-5763-29-3-1-b47","series-title":"Clin Chem","first-page":"499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald\n WT","year":"1972","unstructured":"Friedewald\n WT\n , LevyRI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502."},{"issue":"2","key":"i1945-5763-29-3-1-b48","series-title":"J Eng Technol","first-page":"38","article-title":"Peirce's criterion for the elimination of suspect experimental data","volume":"20","author":"Ross\n SM","year":"2003","unstructured":"Ross\n SM\n \n . Peirce's criterion for the elimination of suspect experimental data. J Eng Technol. 2003;20(2):38-41."},{"issue":"7","key":"i1945-5763-29-3-1-b49","series-title":"J Clin Endocrinol Metab","first-page":"2523","article-title":"Salicylates increase insulin secretion in healthy obese subjects","volume":"93","author":"Fernandez-Real\n JM","year":"2008","unstructured":"Fernandez-Real\n JM\n , Lopez-BermejoA, RoperoAB, et al.\n Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab. 2008;93(7):2523-2530."},{"issue":"10","key":"i1945-5763-29-3-1-b50","series-title":"J Clin Invest","first-page":"1321","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal\n RS","year":"2002","unstructured":"Hundal\n RS\n , PetersenKF, MayersonAB, et al.\n Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109(10):1321-1326."},{"key":"i1945-5763-29-3-1-b51","series-title":"Diabetologia","first-page":"1","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","author":"Goldfine\n A","year":"2013","unstructured":"Goldfine\n A\n , ConlinP, HalperinF, et al.\n A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia. 2013:1-10."},{"key":"i1945-5763-29-3-1-b52","series-title":"Endocrine Pract","first-page":"1","article-title":"Salsalate reduces insulin resistance and plasma glucose level in persons with prediabetes","author":"Faghihimani\n E","year":"2012","unstructured":"Faghihimani\n E\n , AminorroayaA, RezvanianH, et al.\n Salsalate reduces insulin resistance and plasma glucose level in persons with prediabetes. Endocrine Pract. 2012:1-17."},{"issue":"7","key":"i1945-5763-29-3-1-b53","series-title":"Diabetes Care","first-page":"1634","article-title":"Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans","volume":"34","author":"Chai\n W","year":"2011","unstructured":"Chai\n W\n , LiuJ, JahnLA, FowlerDE, BarrettEJ, LiuZ. Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. Diabetes Care. 2011Jul;34(7):1634-8."},{"issue":"1","key":"i1945-5763-29-3-1-b54","series-title":"Am J Physiol Endocrinol Metab","first-page":"E145","article-title":"Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors","volume":"300","author":"Dasu\n MR","year":"2011","unstructured":"Dasu\n MR\n , JialalI. Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors. Am J Physiol Endocrinol Metab. 2011;300(1):E145-54."},{"issue":"2","key":"i1945-5763-29-3-1-b55","series-title":"Nat Rev Immunol","first-page":"98","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath\n MY","year":"2011","unstructured":"Donath\n MY\n , ShoelsonSE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98-107."},{"issue":"2","key":"i1945-5763-29-3-1-b56","series-title":"Clin Chem","first-page":"162","article-title":"Therapeutic approaches to target inflammation in type 2 diabetes","volume":"57","author":"Goldfine\n AB","year":"2011","unstructured":"Goldfine\n AB\n , FonsecaV, ShoelsonSE. Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem. 2011;57(2):162-167."},{"issue":"10","key":"i1945-5763-29-3-1-b57","series-title":"Nutr Rev","first-page":"599","article-title":"Effect of diet on adiponectin levels in blood","volume":"69","author":"Silva\n FM","year":"2011","unstructured":"Silva\n FM\n , de AlmeidaJC, FeoliAM. Effect of diet on adiponectin levels in blood. Nutr Rev. 2011;69(10):599-612."},{"key":"i1945-5763-29-3-1-b58","series-title":"Diabetologia","article-title":"Adiponectin: Mechanistic insights and clinical implications [published online ahead of print June 12, 2012]","author":"Turer\n AT","year":"2012","unstructured":"Turer\n AT\n , SchererPE. Adiponectin: Mechanistic insights and clinical implications [published online ahead of print June 12, 2012]. Diabetologia. 2012Jun12."},{"issue":"1","key":"i1945-5763-29-3-1-b59","series-title":"J Appl Physiol","first-page":"63","article-title":"Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status","volume":"107","author":"Dixon\n NC","year":"2009","unstructured":"Dixon\n NC\n , HurstTL, TalbotDC, TyrrellRM, ThompsonD. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. J Appl Physiol. 2009;107(1):63-68."},{"issue":"7","key":"i1945-5763-29-3-1-b60","series-title":"J Am Coll Cardiol","first-page":"1145","article-title":"Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals","volume":"39","author":"Nappo\n F","year":"2002","unstructured":"Nappo\n F\n , EspositoK, CioffiM, et al.\n Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39(7):1145-1150."},{"issue":"4","key":"i1945-5763-29-3-1-b61","series-title":"Am J Clin Nutr","first-page":"940","article-title":"Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression","volume":"91","author":"Ghanim\n H","year":"2010","unstructured":"Ghanim\n H\n , SiaCL, UpadhyayM, et al.\n Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am J Clin Nutr. 2010;91(4):940-949."},{"issue":"7","key":"i1945-5763-29-3-1-b1","series-title":"Spinal Cord","first-page":"466","article-title":"Coronary heart disease in individuals with spinal cord injury: Assessment of risk factors","volume":"46","author":"Bauman\n WA","year":"2008","unstructured":"Bauman\n WA\n , SpungenAM. Coronary heart disease in individuals with spinal cord injury: Assessment of risk factors. Spinal Cord. 2008;46(7):466-476."},{"issue":"6","key":"i1945-5763-29-3-1-b2","series-title":"Arch Phys Med Rehabil","first-page":"751","article-title":"A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia","volume":"88","author":"Nash\n MS","year":"2007","unstructured":"Nash\n MS\n , MendezAJ. A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia. Arch Phys Med Rehabil. 2007;88(6):751-757."},{"issue":"2","key":"i1945-5763-29-3-1-b3","series-title":"Assist Technol","first-page":"88","article-title":"Metabolic and endocrine changes in persons aging with spinal cord injury","volume":"11","author":"Bauman\n WA","year":"1999","unstructured":"Bauman\n WA\n , SpungenAM, AdkinsRH, KempBJ. Metabolic and endocrine changes in persons aging with spinal cord injury. Assist Technol. 1999;11(2):88-96."},{"issue":"9","key":"i1945-5763-29-3-1-b4","series-title":"Spinal Cord","first-page":"601","article-title":"Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury","volume":"37","author":"Bauman\n WA","year":"1999","unstructured":"Bauman\n WA\n , KahnNN, GrimmDR, SpungenAM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37(9):601-616."},{"issue":"4","key":"i1945-5763-29-3-1-b5","series-title":"J Spinal Cord Med","first-page":"468","article-title":"Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia","volume":"38","author":"Ellenbroek\n D","year":"2015","unstructured":"Ellenbroek\n D\n , KresslerJ, CowanRE, BurnsPA, MendezAJ, NashMS. Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia. J Spinal Cord Med. 2015;38(4):468-475."},{"key":"i1945-5763-29-3-1-b6","series-title":"Int J Vasc Med","first-page":"947417","article-title":"Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases","volume":"2012","author":"Klop\n B","year":"2012","unstructured":"Klop\n B\n , ProctorSD, MamoJC, BothamKM, Castro CabezasM. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med. 2012;2012:947417."},{"key":"i1945-5763-29-3-1-b7","series-title":"Can J Cardiol","first-page":"18B","article-title":"Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins","volume":"14","author":"Cohn\n JS","year":"1998","unstructured":"Cohn\n JS\n \n . Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol. 1998;14(Suppl B):18B-27B."},{"issue":"2","key":"i1945-5763-29-3-1-b8","series-title":"Atherosclerosis","first-page":"307","article-title":"Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men","volume":"141","author":"Karpe\n F","year":"1998","unstructured":"Karpe\n F\n , de FaireU, MercuriM, BondMG, HelleniusML, HamstenA. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis. 1998;141(2):307-314."},{"issue":"1","key":"i1945-5763-29-3-1-b9","series-title":"Int J Cardiol","first-page":"3","article-title":"Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus","volume":"126","author":"Pastromas\n S","year":"2008","unstructured":"Pastromas\n S\n , TerziAB, TousoulisD, KoulourisS. Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol. 2008;126(1):3-12."},{"issue":"1","key":"i1945-5763-29-3-1-b10","series-title":"Cardiovasc Diabetol","first-page":"61","article-title":"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins","volume":"10","author":"Ansar\n S","year":"2011","unstructured":"Ansar\n S\n , KoskaJ, ReavenPD. Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins. Cardiovasc Diabetol. 2011;10(1):61."},{"issue":"4","key":"i1945-5763-29-3-1-b11","series-title":"J Spinal Cord Med","first-page":"320","article-title":"Evidence for an exaggerated postprandial lipemia in chronic paraplegia","volume":"28","author":"Nash\n MS","year":"2005","unstructured":"Nash\n MS\n , DeGrootJ, Martinez-ArizalaA, MendezAJ. Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med. 2005;28(4):320-5."},{"issue":"5","key":"i1945-5763-29-3-1-b12","series-title":"J Am Coll Nutr","first-page":"476","article-title":"The influence of visceral fat on the postprandial lipemic response in men with paraplegia","volume":"29","author":"Emmons\n RR","year":"2010","unstructured":"Emmons\n RR\n , GarberCE, CirnigliaroCM, et al.\n The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr. 2010;29(5):476-81."},{"key":"i1945-5763-29-3-1-b13","series-title":"MSSE","first-page":"404","article-title":"Exaggerated postprandial triglyceride response identified in individuals with spinal cord injury with cardiac risk factors","volume":"41","author":"Emmons\n RR","year":"2009","unstructured":"Emmons\n RR\n , CirnigliaroCM, MoyerJM, et al.\n Exaggerated postprandial triglyceride response identified in individuals with spinal cord injury with cardiac risk factors. MSSE. 2009;41(5 Suppl 1):404-405."},{"key":"i1945-5763-29-3-1-b14","series-title":"Int J Obes Relat Metab Disord","first-page":"S29","article-title":"Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging","volume":"27","author":"Tracy\n RP","year":"2003","unstructured":"Tracy\n RP\n \n . Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S29-34."},{"issue":"3","key":"i1945-5763-29-3-1-b15","series-title":"Rev Endocr Metab Disord","first-page":"255","article-title":"Inflammation in atherosclerosis and diabetes mellitus","volume":"5","author":"Plutzky\n J","year":"2004","unstructured":"Plutzky\n J\n \n . Inflammation in atherosclerosis and diabetes mellitus. Rev Endocr Metab Disord. 2004;5(3):255-259."},{"issue":"10","key":"i1945-5763-29-3-1-b16","series-title":"Circulation","first-page":"1211","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment","volume":"106","author":"Ceriello\n A","year":"2002","unstructured":"Ceriello\n A\n , TabogaC, TonuttiL, et al.\n Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment. Circulation. 2002;106(10):1211-1218."},{"issue":"4","key":"i1945-5763-29-3-1-b17","series-title":"J Clin Invest","first-page":"635","article-title":"Acute hyperglycemia induces an oxidative stress in healthy subjects","volume":"108","author":"Marfella\n R","year":"2001","unstructured":"Marfella\n R\n , QuagliaroL, NappoF, CerielloA, GiuglianoD. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001;108(4):635-636."},{"issue":"2","key":"i1945-5763-29-3-1-b18","series-title":"Atherosclerosis","first-page":"517","article-title":"Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress","volume":"155","author":"Bae\n JH","year":"2001","unstructured":"Bae\n JH\n , BassengeE, KimKB, KimYN, KimKS, LeeHJ, et al.\n Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001;155(2):517-523."},{"issue":"3","key":"i1945-5763-29-3-1-b19","series-title":"Diabetes","first-page":"701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello\n A","year":"2004","unstructured":"Ceriello\n A\n , QuagliaroL, PiconiL, et al.\n Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes. 2004;53(3):701-710."},{"issue":"2","key":"i1945-5763-29-3-1-b20","series-title":"Am Heart J","first-page":"218","article-title":"Endothelial dysfunction: Clinical strategies for treating oxidant stress","volume":"146","author":"Fenster\n BE","year":"2003","unstructured":"Fenster\n BE\n , TsaoPS, RocksonSG. Endothelial dysfunction: Clinical strategies for treating oxidant stress. Am Heart J. 2003;146(2):218-226."},{"issue":"23","key":"i1945-5763-29-3-1-b21","series-title":"Circulation","first-page":"3599","article-title":"Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles","volume":"110","author":"Ferreira\n AC","year":"2004","unstructured":"Ferreira\n AC\n , PeterAA, MendezAJ, et al.\n Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation. 2004;110(23):3599-3603."},{"issue":"9","key":"i1945-5763-29-3-1-b22","series-title":"Circulation","first-page":"1135","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby\n P","year":"2002","unstructured":"Libby\n P\n , RidkerPM, MaseriA. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143."},{"issue":"1","key":"i1945-5763-29-3-1-b23","series-title":"Hypertension","first-page":"6","article-title":"C-reactive protein: Risk marker or mediator in atherothrombosis?","volume":"44","author":"Jialal\n I","year":"2004","unstructured":"Jialal\n I\n , DevarajS, VenugopalSK. C-reactive protein: Risk marker or mediator in atherothrombosis?Hypertension. 2004;44(1):6-11."},{"issue":"2","key":"i1945-5763-29-3-1-b24","series-title":"Semin Dial","first-page":"129","article-title":"Inflammatory biomarkers and cardiovascular risk: Association or cause and effect?","volume":"19","author":"Rao\n M","year":"2006","unstructured":"Rao\n M\n , JaberBL, BalakrishnanVS. Inflammatory biomarkers and cardiovascular risk: Association or cause and effect?Semin Dial. 2006;19(2):129-135."},{"issue":"21","key":"i1945-5763-29-3-1-b25","series-title":"N Engl J Med","first-page":"2195","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker\n PM","year":"2008","unstructured":"Ridker\n PM\n , DanielsonE, FonsecaFA, et al.\n Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-207."},{"issue":"4","key":"i1945-5763-29-3-1-b26","series-title":"Am J Pathol","first-page":"1139","article-title":"C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance","volume":"167","author":"Sun\n H","year":"2005","unstructured":"Sun\n H\n , KoikeT, IchikawaT, HatakeyamaK, ShiomiM, ZhangB, et al.\n C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance. Am J Pathol. 2005;167(4):1139-1148."},{"issue":"1","key":"i1945-5763-29-3-1-b27","series-title":"Diabetes Metab","first-page":"65","article-title":"Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects","volume":"29","author":"Guerrero-Romero\n F","year":"2003","unstructured":"Guerrero-Romero\n F\n , Rodriguez-MoranM. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects. Diabetes Metab. 2003;29(1):65-71."},{"issue":"2","key":"i1945-5763-29-3-1-b28","series-title":"Atherosclerosis","first-page":"387","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen\n E","year":"2003","unstructured":"Leinonen\n E\n , Hurt-CamejoE, WiklundO, HultenLM, HiukkaA, TaskinenMR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 2003;166(2):387-394."},{"issue":"23","key":"i1945-5763-29-3-1-b29","series-title":"Circulation","first-page":"2908","article-title":"Differentiation between obesity and insulin resistance in the association with C-reactive protein","volume":"106","author":"McLaughlin\n T","year":"2002","unstructured":"McLaughlin\n T\n , AbbasiF, LamendolaC, et al.\n Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106(23):2908-2912."},{"issue":"10","key":"i1945-5763-29-3-1-b30","series-title":"J Am Coll Cardiol","first-page":"2003","article-title":"The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome","volume":"44","author":"Aronson\n D","year":"2004","unstructured":"Aronson\n D\n , SellaR, Sheikh-AhmadM, et al.\n The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004;44(10):2003-2007."},{"issue":"1","key":"i1945-5763-29-3-1-b31","series-title":"Circulation","first-page":"42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS)","volume":"102","author":"Festa\n A","year":"2000","unstructured":"Festa\n A\n , D\u2019AgostinoR, Jr, HowardG, MykkanenL, TracyRP, HaffnerSM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102(1):42-47."},{"issue":"2","key":"i1945-5763-29-3-1-b32","series-title":"J Hum Hypertens","first-page":"149","article-title":"Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension","volume":"19","author":"Bautista\n LE","year":"2005","unstructured":"Bautista\n LE\n , VeraLM, ArenasIA, GamarraG. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19(2):149-154."},{"issue":"11","key":"i1945-5763-29-3-1-b33","series-title":"Metabolism","first-page":"1436","article-title":"Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels","volume":"53","author":"Fredrikson\n GN","year":"2004","unstructured":"Fredrikson\n GN\n , HedbladB, NilssonJA, AlmR, BerglundG, NilssonJ. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism. 2004;53(11):1436-1442."},{"issue":"3","key":"i1945-5763-29-3-1-b34","series-title":"Thromb Res","first-page":"245","article-title":"The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases","volume":"82","author":"Grau\n AJ","year":"1996","unstructured":"Grau\n AJ\n , BuggleF, BecherH, WerleE, HackeW. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996;82(3):245-255."},{"issue":"1","key":"i1945-5763-29-3-1-b35","series-title":"Diabetes Res Clin Pract","first-page":"37","article-title":"Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus","volume":"58","author":"Mojiminiyi\n OA","year":"2002","unstructured":"Mojiminiyi\n OA\n , AbdellaN, MoussaMA, AkanjiAO, Al MohammediH, ZakiM. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2002;58(1):37-44."},{"issue":"6","key":"i1945-5763-29-3-1-b36","series-title":"Hypertension","first-page":"859","article-title":"Inflammation, abdominal obesity, and smoking as predictors of hypertension","volume":"44","author":"Niskanen\n L","year":"2004","unstructured":"Niskanen\n L\n , LaaksonenDE, NyyssonenK, et al.\n Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004;44(6):859-865."},{"issue":"4","key":"i1945-5763-29-3-1-b37","series-title":"Int J Obes Relat Metab Disord","first-page":"443","article-title":"The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state","volume":"27","author":"Tamakoshi\n K","year":"2003","unstructured":"Tamakoshi\n K\n , YatsuyaH, KondoT, et al.\n The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord. 2003;27(4):443-449."},{"issue":"2","key":"i1945-5763-29-3-1-b38","series-title":"Arch Phys Med Rehabil","first-page":"312","article-title":"Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury","volume":"86","author":"Frost\n F","year":"2005","unstructured":"Frost\n F\n , RoachMJ, KushnerI, SchreiberP. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil. 2005;86(2):312-317."},{"issue":"3","key":"i1945-5763-29-3-1-b39","series-title":"Curr Opin Clin Nutr Metab Care","first-page":"271","article-title":"Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection","volume":"5","author":"Lang\n CH","year":"2002","unstructured":"Lang\n CH\n , FrostRA. Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care. 2002;5(3):271-279."},{"issue":"2","key":"i1945-5763-29-3-1-b40","series-title":"Diabetes Care","first-page":"289","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman\n A","year":"2008","unstructured":"Fleischman\n A\n , ShoelsonSE, BernierR, GoldfineAB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 2008;31(2):289-294."},{"issue":"6","key":"i1945-5763-29-3-1-b41","series-title":"Ann Intern Med","first-page":"346","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial","volume":"152","author":"Goldfine\n AB","year":"2010","unstructured":"Goldfine\n AB\n , FonsecaV, JablonskiKA, et al.\n The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial. Ann Intern Med. 2010;152(6):346-357."},{"issue":"1","key":"i1945-5763-29-3-1-b42","series-title":"Clin Transl Sci","first-page":"36","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine\n AB","year":"2008","unstructured":"Goldfine\n AB\n , SilverR, AldhahiW, et al.\n Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci. 2008;1(1):36-43."},{"issue":"3","key":"i1945-5763-29-3-1-b43","series-title":"Diabetologia","first-page":"385","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: Results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska\n J","year":"2009","unstructured":"Koska\n J\n , OrtegaE, BuntJC, et al.\n The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: Results of a randomised double-blind placebo-controlled study. Diabetologia. 2009;52(3):385-393."},{"issue":"5","key":"i1945-5763-29-3-1-b44","series-title":"J Spinal Cord Med","first-page":"538","article-title":"International standards for neurological classification of spinal cord injury: Training effect on accurate classification","volume":"31","author":"Chafetz\n RS","year":"2008","unstructured":"Chafetz\n RS\n , VogelLC, BetzRR, GaughanJP, MulcaheyMJ. International standards for neurological classification of spinal cord injury: Training effect on accurate classification. J Spinal Cord Med. 2008;31(5):538-542."},{"issue":"1","key":"i1945-5763-29-3-1-b45","series-title":"J Spinal Cord Med","first-page":"2","article-title":"Circuit resistance training improves the atherogenic lipid profiles of persons with chronic paraplegia","volume":"24","author":"Nash\n MS","year":"2001","unstructured":"Nash\n MS\n , JacobsPL, MendezAJ, GoldbergRB. Circuit resistance training improves the atherogenic lipid profiles of persons with chronic paraplegia. J Spinal Cord Med. 2001;24(1):2-9."},{"key":"i1945-5763-29-3-1-b46","series-title":"Methods Enzymol","first-page":"78","article-title":"Precipitation methods for quantification of lipoproteins","volume":"129","author":"Bachorik\n PS","year":"1986","unstructured":"Bachorik\n PS\n , AlbersJJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986;129:78-100."},{"issue":"6","key":"i1945-5763-29-3-1-b47","series-title":"Clin Chem","first-page":"499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald\n WT","year":"1972","unstructured":"Friedewald\n WT\n , LevyRI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502."},{"issue":"2","key":"i1945-5763-29-3-1-b48","series-title":"J Eng Technol","first-page":"38","article-title":"Peirce's criterion for the elimination of suspect experimental data","volume":"20","author":"Ross\n SM","year":"2003","unstructured":"Ross\n SM\n \n . Peirce's criterion for the elimination of suspect experimental data. J Eng Technol. 2003;20(2):38-41."},{"issue":"7","key":"i1945-5763-29-3-1-b49","series-title":"J Clin Endocrinol Metab","first-page":"2523","article-title":"Salicylates increase insulin secretion in healthy obese subjects","volume":"93","author":"Fernandez-Real\n JM","year":"2008","unstructured":"Fernandez-Real\n JM\n , Lopez-BermejoA, RoperoAB, et al.\n Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab. 2008;93(7):2523-2530."},{"issue":"10","key":"i1945-5763-29-3-1-b50","series-title":"J Clin Invest","first-page":"1321","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal\n RS","year":"2002","unstructured":"Hundal\n RS\n , PetersenKF, MayersonAB, et al.\n Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109(10):1321-1326."},{"key":"i1945-5763-29-3-1-b51","series-title":"Diabetologia","first-page":"1","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","author":"Goldfine\n A","year":"2013","unstructured":"Goldfine\n A\n , ConlinP, HalperinF, et al.\n A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia. 2013:1-10."},{"key":"i1945-5763-29-3-1-b52","series-title":"Endocrine Pract","first-page":"1","article-title":"Salsalate reduces insulin resistance and plasma glucose level in persons with prediabetes","author":"Faghihimani\n E","year":"2012","unstructured":"Faghihimani\n E\n , AminorroayaA, RezvanianH, et al.\n Salsalate reduces insulin resistance and plasma glucose level in persons with prediabetes. Endocrine Pract. 2012:1-17."},{"issue":"7","key":"i1945-5763-29-3-1-b53","series-title":"Diabetes Care","first-page":"1634","article-title":"Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans","volume":"34","author":"Chai\n W","year":"2011","unstructured":"Chai\n W\n , LiuJ, JahnLA, FowlerDE, BarrettEJ, LiuZ. Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. Diabetes Care. 2011Jul;34(7):1634-8."},{"issue":"1","key":"i1945-5763-29-3-1-b54","series-title":"Am J Physiol Endocrinol Metab","first-page":"E145","article-title":"Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors","volume":"300","author":"Dasu\n MR","year":"2011","unstructured":"Dasu\n MR\n , JialalI. Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors. Am J Physiol Endocrinol Metab. 2011;300(1):E145-54."},{"issue":"2","key":"i1945-5763-29-3-1-b55","series-title":"Nat Rev Immunol","first-page":"98","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath\n MY","year":"2011","unstructured":"Donath\n MY\n , ShoelsonSE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98-107."},{"issue":"2","key":"i1945-5763-29-3-1-b56","series-title":"Clin Chem","first-page":"162","article-title":"Therapeutic approaches to target inflammation in type 2 diabetes","volume":"57","author":"Goldfine\n AB","year":"2011","unstructured":"Goldfine\n AB\n , FonsecaV, ShoelsonSE. Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem. 2011;57(2):162-167."},{"issue":"10","key":"i1945-5763-29-3-1-b57","series-title":"Nutr Rev","first-page":"599","article-title":"Effect of diet on adiponectin levels in blood","volume":"69","author":"Silva\n FM","year":"2011","unstructured":"Silva\n FM\n , de AlmeidaJC, FeoliAM. Effect of diet on adiponectin levels in blood. Nutr Rev. 2011;69(10):599-612."},{"key":"i1945-5763-29-3-1-b58","series-title":"Diabetologia","article-title":"Adiponectin: Mechanistic insights and clinical implications [published online ahead of print June 12, 2012]","author":"Turer\n AT","year":"2012","unstructured":"Turer\n AT\n , SchererPE. Adiponectin: Mechanistic insights and clinical implications [published online ahead of print June 12, 2012]. Diabetologia. 2012Jun12."},{"issue":"1","key":"i1945-5763-29-3-1-b59","series-title":"J Appl Physiol","first-page":"63","article-title":"Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status","volume":"107","author":"Dixon\n NC","year":"2009","unstructured":"Dixon\n NC\n , HurstTL, TalbotDC, TyrrellRM, ThompsonD. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. J Appl Physiol. 2009;107(1):63-68."},{"issue":"7","key":"i1945-5763-29-3-1-b60","series-title":"J Am Coll Cardiol","first-page":"1145","article-title":"Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals","volume":"39","author":"Nappo\n F","year":"2002","unstructured":"Nappo\n F\n , EspositoK, CioffiM, et al.\n Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39(7):1145-1150."},{"issue":"4","key":"i1945-5763-29-3-1-b61","series-title":"Am J Clin Nutr","first-page":"940","article-title":"Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression","volume":"91","author":"Ghanim\n H","year":"2010","unstructured":"Ghanim\n H\n , SiaCL, UpadhyayM, et al.\n Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am J Clin Nutr. 2010;91(4):940-949."}],"container-title":["Topics in Spinal Cord Injury Rehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/29\/3\/article-p1.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/tscir\/article-pdf\/29\/3\/1\/3283247\/i1945-5763-29-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/29\/3\/article-p1.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/29\/3\/article-p1.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:50:36Z","timestamp":1775145036000},"score":1,"resource":{"primary":{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/29\/3\/article-p1.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":122,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.46292\/sci22-00033","relation":{},"ISSN":["1082-0744","1945-5763"],"issn-type":[{"value":"1082-0744","type":"print"},{"value":"1945-5763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}